Castro-Fernández DC, Cañizo-Outeiriño A, Martínez AL, Cuartero-Martinez A, Rodríguez-Martínez L, González-Barcia M, Fernández-Rodríguez MI, Rodríguez-Cid MJ, Abraldes MJ, Almuiña-Varela P, Mera-Yáñez MP, de Domingo B, Gil-Martínez M, Méndez-Cepeda MDP, Pazos-González B, Goméz-Ulla F, Loza MI, Ortea I, Brea J, Mateos J, Fernández-Ferreiro A
European Journal of Medicinal Chemistry 320 119361 (2026)
Background and purpose Neovascular age-related macular degeneration is a leading cause of irreversible blindness, and approximately 25% of patients respond inadequately to intravitreal anti-VEGF therapy, representing a major unmet clinical need. We aimed to identify repurposable therapeutic alternatives by anchoring a phenotypic screen in the molecular signature of inadequate responders. Experimental approach The molecular phenotype […]